Showing results (51-60 of 94) with videos related to
Sort By:
Pageof 10
Schizophrenia Research|April 30, 2017
Paliperidone palmitate once-monthly maintains improvement in functioning domains of the Personal and Social Performance scale compared with placebo in subjects with schizoaffective disorderDong-Jing Fu, Ibrahim Turkoz, David Walling, et al.The International Journal of Neuropsychopharmacology|February 1, 2024
Relapse Rates With Paliperidone Palmitate in Adult Patients With Schizophrenia: Results for the 6-Month Formulation From an Open-label Extension Study Compared to Real-World Data for the 1-Month and 3-Month FormulationsIbrahim Turkoz, Mehmet Daskiran, Uzma Siddiqui, et al.CNS Spectrums|April 1, 2024
Effects of esketamine nasal spray on depressive symptom severity in adults with treatment-resistant depression and associations between the Montgomery-Åsberg Depression Rating Scale and the 9-item Patient Health QuestionnaireJennifer Kern Sliwa, Ronaldo R Naranjo, Ibrahim Turkoz, et al.Journal of Affective Disorders|October 23, 2022
Intranasal esketamine effectively treats treatment-resistant depression in adults regardless of baseline irritabilityManish K Jha, David J Williamson, Ghazal Magharehabed, et al.Therapeutic Advances in Psychopharmacology|October 3, 2023
Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophreniaIbrahim Turkoz, Joshua Wong, Benjamin Chee, et al.Journal of Women'S Health (2002)|February 1, 2024
Efficacy and Safety of Ponesimod Compared with Teriflunomide in Female Patients with Relapsing Multiple Sclerosis: Findings from the Pivotal OPTIMUM StudyRobyn R Jones, Ibrahim Turkoz, Maria Ait-Tihyaty, et al.Psychiatry Research|October 17, 2020
Suicide Ideation and Behavior Assessment Tool (SIBAT): Evaluation of Intra- and Inter-Rater Reliability, Validity, and Mapping to Columbia Classification Algorithm of Suicide AssessmentLarry Alphs, Dong-Jing Fu, David Williamson, et al.International Clinical Psychopharmacology|June 12, 2008
Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidoneCarla M Canuso, Eriene A Youssef, Cynthia A Bossie, et al.Bipolar Disorders|November 20, 2009
A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequentlyWayne Macfadden, Larry Alphs, J Thomas Haskins, et al.International Clinical Psychopharmacology|March 15, 2016
Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapyLarry Alphs, Henry A Nasrallah, Cynthia A Bossie, et al.Pageof 10